| Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease C Liguori, A Romigi, M Nuccetelli, S Zannino, G Sancesario, A Martorana, ... JAMA neurology 71 (12), 1498-1505, 2014 | 322 | 2014 |
| Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection C Liguori, M Pierantozzi, M Spanetta, L Sarmati, N Cesta, M Iannetta, ... Brain, behavior, and immunity 88, 11-16, 2020 | 249 | 2020 |
| Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer’s disease biomarkers changes C Liguori, NB Mercuri, F Izzi, A Romigi, A Cordella, G Sancesario, ... Sleep 40 (5), zsx011, 2017 | 243 | 2017 |
| Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder MG Miglis, CH Adler, E Antelmi, D Arnaldi, L Baldelli, BF Boeve, M Cesari, ... The Lancet Neurology 20 (8), 671-684, 2021 | 207 | 2021 |
| CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease C Liguori, A Stefani, G Sancesario, GM Sancesario, MG Marciani, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (6), 655-659, 2015 | 146 | 2015 |
| Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's … C Liguori, M Nuccetelli, F Izzi, G Sancesario, A Romigi, A Martorana, ... Neurobiology of aging 40, 120-126, 2016 | 139 | 2016 |
| Sleep-disordered breathing and the risk of Alzheimer's disease C Liguori, M Maestri, M Spanetta, F Placidi, E Bonanni, NB Mercuri, ... Sleep Medicine Reviews 55, 101375, 2021 | 119 | 2021 |
| Cerebrospinal fluid lactate levels and brain [18F] FDG PET hypometabolism within the default mode network in Alzheimer’s disease C Liguori, A Chiaravalloti, G Sancesario, A Stefani, GM Sancesario, ... European journal of nuclear medicine and molecular imaging 43, 2040-2049, 2016 | 109 | 2016 |
| Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology C Costa, M Romoli, C Liguori, L Farotti, P Eusebi, C Bedetti, S Siliquini, ... Neurobiology of Aging 73, 61-67, 2019 | 102 | 2019 |
| Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy T Schirinzi, R Cerroni, G Di Lazzaro, C Liguori, S Scalise, R Bovenzi, ... Neurological Sciences 41, 1373-1375, 2020 | 90 | 2020 |
| COVID-19: dealing with a potential risk factor for chronic neurological disorders T Schirinzi, D Landi, C Liguori Journal of neurology 268 (4), 1171-1178, 2021 | 85 | 2021 |
| Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? C Costa, L Parnetti, M D'Amelio, A Tozzi, M Tantucci, A Romigi, S Siliquini, ... Neurobiology of aging 48, 161-171, 2016 | 85 | 2016 |
| Effects of anti-seizure medications on sleep architecture and daytime sleepiness in patients with epilepsy: a literature review C Liguori, M Toledo, S Kothare Sleep Medicine Reviews 60, 101559, 2021 | 82 | 2021 |
| Orexin and Alzheimer’s disease C Liguori Behavioral neuroscience of orexin/hypocretin, 305-322, 2017 | 81 | 2017 |
| Continuous positive airway pressure treatment increases serum vitamin D levels in male patients with obstructive sleep apnea C Liguori, A Romigi, F Izzi, NB Mercuri, A Cordella, E Tarquini, ... Journal of Clinical Sleep Medicine 11 (6), 603-607, 2015 | 80 | 2015 |
| Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study M Pierantozzi, F Placidi, C Liguori, M Albanese, P Imbriani, MG Marciani, ... Sleep medicine 21, 140-144, 2016 | 76 | 2016 |
| Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? C Liguori, NB Mercuri, M Nuccetelli, F Izzi, A Cordella, S Bernardini, ... Sleep medicine 56, 171-176, 2019 | 71 | 2019 |
| Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study S Joza, MT Hu, KY Jung, D Kunz, A Stefani, P Dušek, M Terzaghi, ... Brain 146 (8), 3258-3272, 2023 | 68 | 2023 |
| Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course C Liguori, F Placidi, F Izzi, M Spanetta, NB Mercuri, A Di Pucchio Alzheimer's research & therapy 12, 1-13, 2020 | 67 | 2020 |
| Sleep-wake cycle in Alzheimer’s disease is associated with tau pathology and orexin dysregulation C Liguori, M Spanetta, F Izzi, F Franchini, M Nuccetelli, GM Sancesario, ... Journal of Alzheimer’s Disease 74 (2), 501-508, 2020 | 66 | 2020 |
